Ohe Y - Search Results

1

BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors.

Itahashi K, Irie T, Yuda J, Kumagai S, Tanegashima T, Lin YT, Watanabe S, Goto Y, Suzuki J, Aokage K, Tsuboi M, Minami Y, Ishii G, Ohe Y, Ise W, Kurosaki T, Suzuki Y, Koyama S, Nishikawa H. Itahashi K, et al. Among authors: ohe y. Sci Immunol. 2022 Oct 14;7(76):eabk0957. doi: 10.1126/sciimmunol.abk0957. Epub 2022 Oct 7. Sci Immunol. 2022. PMID: 36206353

2

TRUST-II: a global phase II study of taletrectinib in ROS1-positive non-small-cell lung cancer and other solid tumors.

Nagasaka M, Ohe Y, Zhou C, Choi CM, Yang N, Liu G, Felip E, Pérol M, Besse B, Nieva J, Raez L, Pennell NA, Dimou A, Marinis F, Ciardiello F, Seto T, Hu Z, Pan M, Wang W, Li S, Ou SI. Nagasaka M, et al. Among authors: ohe y. Future Oncol. 2023 Jan;19(2):123-135. doi: 10.2217/fon-2022-1059. Epub 2023 Mar 6. Future Oncol. 2023. PMID: 36877099 Free article.

3

Impact of interstitial lung abnormality on survival after adjuvant durvalumab with chemoradiotherapy for locally advanced non-small cell lung cancer.

Kashihara T, Nakayama Y, Okuma K, Takahashi A, Kaneda T, Katagiri M, Nakayama H, Kubo Y, Ito K, Nakamura S, Takahashi K, Inaba K, Murakami N, Saito T, Okamoto H, Itami J, Kusumoto M, Ohe Y, Igaki H. Kashihara T, et al. Among authors: ohe y. Radiother Oncol. 2023 Mar;180:109454. doi: 10.1016/j.radonc.2022.109454. Epub 2023 Jan 11. Radiother Oncol. 2023. PMID: 36640944 Free article.

4

Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patients.

Goto Y, Sekine I, Yamada K, Nokihara H, Yamamoto N, Kunitoh H, Ohe Y, Tamura T. Goto Y, et al. Among authors: ohe y. J Thorac Oncol. 2008 Apr;3(4):412-6. doi: 10.1097/JTO.0b013e318168d1f1. J Thorac Oncol. 2008. PMID: 18379361 Free article.

5

Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.

Shimada Y, Niho S, Ishii G, Hishida T, Yoshida J, Nishimura M, Yoh K, Goto K, Ohmatsu H, Ohe Y, Nagai K. Shimada Y, et al. Among authors: ohe y. Lung Cancer. 2012 Mar;75(3):368-73. doi: 10.1016/j.lungcan.2011.08.012. Epub 2011 Sep 13. Lung Cancer. 2012. PMID: 21920624

6

Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung.

Taira T, Ishii G, Nagai K, Yoh K, Takahashi Y, Matsumura Y, Kojima M, Ohmatsu H, Goto K, Niho S, Takashima H, Inoue H, Ohe Y, Ochiai A. Taira T, et al. Among authors: ohe y. Lung Cancer. 2012 Jun;76(3):423-30. doi: 10.1016/j.lungcan.2011.11.010. Epub 2011 Dec 6. Lung Cancer. 2012. PMID: 22153829

7

Clinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lung.

Shiozawa T, Ishii G, Goto K, Nagai K, Mimaki S, Ono S, Niho S, Fujii S, Ohe Y, Tsuchihara K, Ochiai A. Shiozawa T, et al. Among authors: ohe y. Pathol Int. 2013 Feb;63(2):77-84. doi: 10.1111/pin.12033. Epub 2013 Feb 21. Pathol Int. 2013. PMID: 23464964

8

Cancer-initiating cell marker-positive cells generate metastatic tumors that recapitulate the histology of the primary tumors.

Nishijima N, Ishii G, Nagai K, Atsumi N, Aokage K, Tokunaga Y, Ichinokawa H, Ohe Y, Ochiai A. Nishijima N, et al. Among authors: ohe y. Pathol Int. 2013 Feb;63(2):94-101. doi: 10.1111/pin.12039. Epub 2013 Feb 22. Pathol Int. 2013. PMID: 23464966

9

Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma.

Yoshida T, Ishii G, Goto K, Yoh K, Niho S, Umemura S, Matsumoto S, Ohmatsu H, Nagai K, Ohe Y, Ochiai A. Yoshida T, et al. Among authors: ohe y. J Cancer Res Clin Oncol. 2013 Oct;139(10):1691-700. doi: 10.1007/s00432-013-1495-0. Epub 2013 Aug 22. J Cancer Res Clin Oncol. 2013. PMID: 23974272

10

Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung.

Takahashi A, Ishii G, Kinoshita T, Yoshida T, Umemura S, Hishida T, Yoh K, Niho S, Goto K, Ohmatsu H, Ohe Y, Nagai K, Ochiai A. Takahashi A, et al. Among authors: ohe y. J Cancer Res Clin Oncol. 2013 Nov;139(11):1869-78. doi: 10.1007/s00432-013-1502-5. Epub 2013 Sep 7. J Cancer Res Clin Oncol. 2013. PMID: 24013219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

701 results

Search Page